The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Hudson, Kathryn Barbara
    Company Secretary born in August 1974
    Individual (13 offsprings)
    Officer
    2023-03-02 ~ now
    OF - Director → CIF 0
  • 2
    Sheppard, Abigail Christine
    Company Director born in August 1981
    Individual (10 offsprings)
    Officer
    2023-03-02 ~ now
    OF - Director → CIF 0
  • 3
    RB PHARMACEUTICALS LIMITED - 2015-07-01
    The Chapleo Building, Henry Boot Way, Priory Way, Hull, United Kingdom
    Active Corporate (8 parents, 3 offsprings)
    Person with significant control
    2023-05-31 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 6
  • 1
    Dr Michael Jeffrey Sinclair
    Born in December 1942
    Individual (25 offsprings)
    Person with significant control
    2016-11-04 ~ 2023-03-02
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Geoffrey Charles Wolf
    Born in August 1953
    Individual (1 offspring)
    Person with significant control
    2016-11-04 ~ 2023-03-02
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    O'toole, David
    Director born in December 1958
    Individual (1 offspring)
    Officer
    2017-09-12 ~ 2023-03-02
    OF - Director → CIF 0
  • 4
    Crystal, Roger
    Director born in September 1976
    Individual
    Officer
    2017-07-07 ~ 2023-03-02
    OF - Director → CIF 0
    Roger Crystal
    Born in September 1976
    Individual
    Person with significant control
    2016-11-04 ~ 2023-03-02
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 5
    Pollack, Kevin Andrew
    Financial Officer born in September 1970
    Individual
    Officer
    2016-11-04 ~ 2017-09-11
    OF - Director → CIF 0
  • 6
    234, Bath Road, Slough, Berkshire, United Kingdom
    Active Corporate (8 parents, 1 offspring)
    Person with significant control
    2023-03-02 ~ 2023-05-31
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

OPIANT PHARMACEUTICALS UK LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Debtors
5,176,655 USD2022-12-31
2,848,006 USD2021-12-31
Cash at bank and in hand
1,611,546 USD2022-12-31
2,214,364 USD2021-12-31
Current Assets
6,788,201 USD2022-12-31
5,062,370 USD2021-12-31
Creditors
Current
4,722,251 USD2022-12-31
3,611,590 USD2021-12-31
Net Current Assets/Liabilities
2,065,950 USD2022-12-31
1,450,780 USD2021-12-31
Total Assets Less Current Liabilities
2,065,950 USD2022-12-31
1,450,780 USD2021-12-31
Creditors
Non-current
469,446 USD2022-12-31
Net Assets/Liabilities
1,596,504 USD2022-12-31
1,450,780 USD2021-12-31
Equity
Called up share capital
100 USD2022-12-31
100 USD2021-12-31
Retained earnings (accumulated losses)
1,596,404 USD2022-12-31
1,450,680 USD2021-12-31
Equity
1,596,504 USD2022-12-31
1,450,780 USD2021-12-31
Average Number of Employees
142022-01-01 ~ 2022-12-31
142021-01-01 ~ 2021-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
40,749 USD2021-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
40,749 USD2021-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment, Under hire purchased contracts or finance leases
40,749 USD2021-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment, Under hire purchased contracts or finance leases
40,749 USD2021-12-31
Amounts Owed by Group Undertakings
Current
4,358,365 USD2022-12-31
1,314,241 USD2021-12-31
Other Debtors
Amounts falling due within one year, Current
818,290 USD2022-12-31
1,533,765 USD2021-12-31
Debtors
Amounts falling due within one year, Current
5,176,655 USD2022-12-31
2,848,006 USD2021-12-31
Trade Creditors/Trade Payables
Current
942,506 USD2022-12-31
108,413 USD2021-12-31
Other Taxation & Social Security Payable
Current
2,731,364 USD2022-12-31
3,429,552 USD2021-12-31
Other Creditors
Current
1,048,381 USD2022-12-31
73,625 USD2021-12-31
Non-current
469,446 USD2022-12-31
  • OPIANT PHARMACEUTICALS UK LIMITED
    Info
    Registered number 10463071
    234 Bath Road, Slough, Berkshire SL1 4EE
    Private Limited Company incorporated on 2016-11-04 (8 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-01
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.